Competitive Generic Therapies: Off-Patent Drugs With 2 Sources
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
This table lists drugs which, despite having no patents or regulatory protections, have a limited number of active sources.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Strength |
---|---|---|---|---|---|---|---|---|---|---|
Lupin Ltd | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 202912-001 | Dec 5, 2013 | AB | RX | No | No | EQ 300MG BASE;150MG;300MG |
Viiv Hlthcare | TRIZIVIR | abacavir sulfate; lamivudine; zidovudine | TABLET;ORAL | 021205-001 | Nov 14, 2000 | AB | RX | Yes | Yes | EQ 300MG BASE;150MG;300MG |
Xspire Pharma | TREZIX | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 204785-001 | Nov 26, 2014 | RX | No | No | 320.5MG;30MG;16MG | |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Strength |